Homebiopharmaceutical

biopharmaceutical

Actinium Pharmaceuticals (ATNM) Outpaces Stock Market Gains: What You Should Know

Actinium Pharmaceuticals (ATNM) Outpaces Stock Market Gains: What You Should Know

December 23, 2020

Acasti Pharma Unaware of Any Material Change

Acasti Pharma Unaware of Any Material Change

December 23, 2020

Roche’s (RHHBY) Phesgo Gets EU Nod to Treat Breast Cancer

Roche’s (RHHBY) Phesgo Gets EU Nod to Treat Breast Cancer

December 23, 2020

Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement

Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement

December 23, 2020

CNS Pharmaceuticals Announces Pricing of $10.0 Million Public Offering

CNS Pharmaceuticals Announces Pricing of $10.0 Million Public Offering

December 23, 2020

CASI Pharmaceuticals Announces CNCT19 (CD19 CAR-T) Receives China Breakthrough Therapy Designation

CASI Pharmaceuticals Announces CNCT19 (CD19 CAR-T) Receives China Breakthrough Therapy Designation

December 23, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline – FBIO

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline – FBIO

December 23, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, BRPA, and TPGY Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, BRPA, and TPGY Shareholders About Its Ongoing Investigations

December 22, 2020

Cellectar Biosciences Announces Proposed Underwritten Public Offering and Concurrent Private Placement

Cellectar Biosciences Announces Proposed Underwritten Public Offering and Concurrent Private Placement

December 22, 2020

ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Celsion Corporation Investors of Important December 29 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – CLSN

ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Celsion Corporation Investors of Important December 29 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – CLSN

December 22, 2020

« 1 … 540 541 542 543 544 … 558 »